These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2262746

  • 1. In vitro drug susceptibility of Mycobacterium other than tubercle bacilli.
    Imwidthaya P, Komolpis P, Suthiravitayavaniz K, Rienthong S.
    J Med Assoc Thai; 1990 Aug; 73(8):438-42. PubMed ID: 2262746
    [Abstract] [Full Text] [Related]

  • 2. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
    Casal M, Rodriguez F, Villalba R, Benavente MC, Gonzalez AI.
    Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
    [Abstract] [Full Text] [Related]

  • 3. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
    Hoel T, Casals JB, Eng J.
    APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
    [Abstract] [Full Text] [Related]

  • 4. Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008.
    Wang HX, Yue J, Han M, Yang JH, Gao RL, Jing LJ, Yang SS, Zhao YL.
    Chin Med J (Engl); 2010 Jan 20; 123(2):184-7. PubMed ID: 20137367
    [Abstract] [Full Text] [Related]

  • 5. [Drug sensitivity of Mycobacterium fortuitum strains isolated from water samples].
    Pelczarska B.
    Pneumonol Pol; 1982 Nov 20; 50(11):609-11. PubMed ID: 7182816
    [No Abstract] [Full Text] [Related]

  • 6. [Comparison of multiple drug-resistance between Mycobacterium avium complex and Mycobacterium fortuitum and Mycobacterium chelonae].
    Tsukamura M.
    Kekkaku; 1988 Aug 20; 63(8):563-8. PubMed ID: 3184587
    [No Abstract] [Full Text] [Related]

  • 7. Single and double drug susceptibility testing of Mycobacterium avium complex and mycobacteria other than the tubercle (MOTT) bacilli by a micro-dilution broth minimum inhibitory concentration (MIC) method.
    Telles MA, Yates MD.
    Tuber Lung Dis; 1994 Aug 20; 75(4):286-90. PubMed ID: 7949075
    [Abstract] [Full Text] [Related]

  • 8. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1995 Feb 20; 70(2):97-101. PubMed ID: 7699982
    [Abstract] [Full Text] [Related]

  • 9. [Clinical studies on lung disease caused by atypical mycobacteria in our hospital--especially in relation to drug susceptibility].
    Mineshita M, Miyazawa T, Doi M, Suei S, Matsuura M, Senoo T, Yamakido M.
    Kekkaku; 1993 Jul 20; 68(7):479-86. PubMed ID: 8361116
    [Abstract] [Full Text] [Related]

  • 10. In vitro susceptibility of Mycobacterium fortuitum and M. chelonei to sisomicin, gentamicin and tobramycin.
    Casal MJ, Rodriguez FC.
    Ann Microbiol (Paris); 1983 Jul 20; 134B(3):451-4. PubMed ID: 6675495
    [Abstract] [Full Text] [Related]

  • 11. [In vitro susceptibility of atypical mycobacteria to Cephem and other antibiotics].
    Sakurai N.
    Kekkaku; 1983 Jun 20; 58(6):355-62. PubMed ID: 6620790
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel.
    Cavusoglu C, Gurpinar T, Ecemis T.
    New Microbiol; 2012 Jan 20; 35(1):73-6. PubMed ID: 22378556
    [Abstract] [Full Text] [Related]

  • 13. [Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo].
    Janowiec M, Andrzejczyk Z, Marczewska J.
    Pneumonol Pol; 1989 May 20; 57(5):300-7. PubMed ID: 2633149
    [Abstract] [Full Text] [Related]

  • 14. [Susceptibility to antimicrobial agents of rapidly growing mycobacteria].
    Ruiz-Aragón J, García-Agudo L, Flores S, Rodríguez MJ, Marín P, García-Martos P.
    Rev Esp Quimioter; 2007 Dec 20; 20(4):429-32. PubMed ID: 18563216
    [Abstract] [Full Text] [Related]

  • 15. [In vitro sensitivity of Mycobacterium chelonae strains to various antimicrobial agents].
    Hernández García AM, Arias A, Felipe A, Alvarez R, Sierra A.
    Microbiologia; 1995 Dec 20; 11(4):485-90. PubMed ID: 8588844
    [Abstract] [Full Text] [Related]

  • 16. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.
    Shen GH, Wu BD, Hu ST, Lin CF, Wu KM, Chen JH.
    Int J Antimicrob Agents; 2010 Apr 20; 35(4):400-4. PubMed ID: 20138481
    [Abstract] [Full Text] [Related]

  • 17. [Mycobacterium fortuitum: the determination of its susceptibility by the disk diffusion technic].
    Ferrá Salazar C, Montoro Cardoso E, Valdivia Alvarez J, Jiménez Misas C, Díaz Rodríguez R.
    Rev Cubana Med Trop; 1992 Apr 20; 44(1):17-20. PubMed ID: 1344681
    [Abstract] [Full Text] [Related]

  • 18. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility.
    Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW.
    Arch Dermatol; 2006 Oct 20; 142(10):1287-92. PubMed ID: 17043183
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial susceptibility testing of rapidly growing mycobacteria by microdilution - experience of a tertiary care centre.
    Set R, Rokade S, Agrawal S, Shastri J.
    Indian J Med Microbiol; 2010 Oct 20; 28(1):48-50. PubMed ID: 20061764
    [Abstract] [Full Text] [Related]

  • 20. [Study of "in vitro" susceptibility of "Mycobacterium fortuitum" to aminoglycoside and beta-lactam antibiotics (author's transl)].
    Casal M, Rodriguez F.
    Ann Microbiol (Paris); 1981 Oct 20; 132B(1):51-6. PubMed ID: 7305191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.